(April 10, 2018) Patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who have had at least a partial response to platinum based chemotherapy have a new, FDA … Continued
(April 4, 2018) It’s an exciting time for ovarian cancer research! Ovarian cancer clinicians, researchers and advocates came together in New Orleans at the end of March for the Annual … Continued
(April 3, 2018) A study in the Journal of Clinical Oncology explored the effects of oncologists, rather than genetic counselors, testing ovarian cancer patients for BRCA mutations. Due to the … Continued
(March 16, 2018) On behalf of Ovarian Cancer Research Alliance I want to extend our deepest condolences on the passing of U.S. Representative Louise Slaughter. As the author of the … Continued
(February 22, 2018) Researchers at Roswell Park Comprehensive Cancer Center, including Kunle Odunsi, MD, PhD, senior author of the study and current OCRFA Scientific Advisory Committee member, have discovered a … Continued
(February 14, 2018) Today the US Preventive Task Force updated their recommendation on ovarian cancer screening, reaffirming their 2012 position that screening average risk women for ovarian cancer is not … Continued
On World Cancer Day, the world comes together to defeat cancer. Ovarian cancer is a worldwide disease. The cure starts right here. At OCRFA, we’re making progress every day toward … Continued
(January 31, 2018) A study published in the Annals of Internal Medicine explains that researchers now believe that the methylation of normal BRCA1 gene promotion, not solely BRCA1 mutation, is … Continued
(January 30, 2018) Ovarian Cancer Research Alliance has hosted Super Saturday in the Hamptons for the past 20 years. Now, we’re delighted to announce that our iconic event will move … Continued
(January 29, 2018) A study recently published in the New England Journal of Medicine looked at the difference between two treatment strategies for newly diagnosed stage III epithelial ovarian cancer … Continued
(January 25, 2018) CancerSEEK is a blood test designed to detect cancer by analyzing levels of proteins and mutations in cell-free DNA. The goal of this particular blood test is … Continued
(January 25, 2018) OCRFA has just awarded more than $5.3 million in new scientific research grants for ovarian cancer, bringing our total investment in life-saving research to over $80 million. … Continued
Get email updates about research news, action alerts, and ways to join the fight.
